Clinical Trial Results:
Randomized, Controlled Phase 2a/b Study of the Efficacy and Safety of PEG-rIL-29
Administered in Combination with Ribavirin to Treatment-Naive Subjects with Chronic
Hepatitis C Virus Infection
Summary
|
|
EudraCT number |
2009-011786-80 |
Trial protocol |
BE ES DE CZ AT FR IT |
Global completion date |
20 Jan 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jun 2022
|
First version publication date |
02 Jun 2022
|
Other versions |
|
Summary report(s) |
526H04 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.